Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.30 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.30 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HTR2C | P28335 | 1/20 | 0.30 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30045043 | 1.00 | FAAH (0.39) | FAAHCNR1CNR2CYP2D6CYP2C19 | |
| SCHEMBL433466 | 0.93 | FAAH (0.36) | FAAHCNR1CNR2 | |
| SCHEMBL7963183 | 0.85 | FAAH (0.45) | FAAHCNR1CNR2CTSKCHRM1 | |
| SCHEMBL27790605 | 0.84 | FAAH (0.36) | FAAHCNR1CNR2CYP2D6CYP2C19 | |
| SCHEMBL1486280 | 0.83 | FAAH (0.40) | FAAHCNR1CNR2CHRM1AKR1A1 | |
| SCHEMBL1486282 | 0.83 | FAAH (0.40) | FAAHCNR1CNR2CHRM1AKR1A1 | |
| SCHEMBL22231266 | 0.82 | CYP2D6 (0.33) | FAAHCYP2D6CYP2C19CTSK | |
| SCHEMBL29560455 | 0.80 | TSHR (0.42) | CYP2D6CYP2C19ADRA1A | |
| SCHEMBL28784725 | 0.79 | FAAH (0.37) | FAAHCNR1CNR2 | |
| SCHEMBL9703749 | 0.79 | CYP2D6 (0.33) | CYP2D6CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2001039766-A2 | SCREENING INVERTEBRATE PHEROMONES FOR THERAPEUTIC ACTIVITY | ALYDAR PHARMACEUTICALS LTD. (IL) | 2001-06-07 | — | — | WO | claimed |
| US-11903387-B2 | Fungicidal composition | GOWAN COMPANY, L.L.C. (US) | 2024-02-20 | — | — | US | disclosed |
| CN-115802893-A | Fungicidal compositions | 先正达农作物保护股份公司 | 2023-03-14 | — | — | CN | disclosed |
| CN-115702153-A | Microbicidal derivatives | 先正达农作物保护股份公司 | 2023-02-14 | — | — | CN | disclosed |
| CN-115244036-A | Pesticidally active diazine-bisamide compounds | 先正达农作物保护股份公司 | 2022-10-25 | — | — | CN | disclosed |
| CN-114401963-A | Pesticidally active cyclic amine compounds | 先正达农作物保护股份公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114341142-A | Strigolactone derivatives as plant growth regulator compounds | 先正达农作物保护股份公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-114269144-A | Precision processing and sowing or planting method and apparatus | 先正达参股股份有限公司 | 2022-04-01 | — | — | CN | disclosed |
| WO-2001039766-A2 | SCREENING INVERTEBRATE PHEROMONES FOR THERAPEUTIC ACTIVITY | ALYDAR PHARMACEUTICALS LTD. (IL) | 2001-06-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11903387-B2 | Fungicidal composition | CYP51A1, CYP4Z1, ERG28 | FAAH 2878/4885CNR1 3645/4885CNR2 4339/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.